A Post-marketing Evaluation of a Compound Traditional Chinese Herbal Medicine, Qishe Pill, on Cervical Radiculopathy

NCT01875562 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2400

Last updated 2013-06-12

No results posted yet for this study

Summary

Neck pain is a common symptom in most patients suffering from cervical radiculopathy. However, some conservative treatments are limited by their modest effectiveness. On the other hand, surgical intervention for cervical disc disorders is indicated when symptoms are refractory to conservative treatments and neurological symptoms are progressive. Many patients use complementary and alternative medicine, including Traditional Chinese Medicine, to address their symptoms. The purpose of the present study is to examine effectiveness and safety of Qishe Pill, a compound traditional Chinese herbal medicine, for neck pain in patients with cervical radiculopathy.

Conditions

  • Cervical Radiculopathy

Interventions

DRUG

Qishe Pill

Pill, 3.75 g, twice per day, four weeks

Sponsors & Collaborators

  • Huadong Hospital

    collaborator OTHER
  • Shanghai East Hospital

    collaborator OTHER
  • Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

    collaborator OTHER
  • Shanghai No.1 Hospital

    collaborator UNKNOWN
  • Shanghai No.6 Hospital

    collaborator UNKNOWN
  • Changhai Hospital

    collaborator OTHER
  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Yongjun Wang, Dr · Longhua Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-10-31
Completion
2013-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01875562 on ClinicalTrials.gov